← Back to Dashboard

Pradefovir mesylate

Nucleotide reverse transcriptase inhibitor

2D Structure

Structure not available

3D Structure

No structure available on PubChemSearch PubChem

Chemical Identifiers

PubChemClinicalTrials.govPubMed

Clinical Development by Virus1

Hepatitis B virus
HBV
Target: Viral DNA pol
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
China
Approval ref (english.nmpa.gov.cn) Xi'an Gelan Xintong Pharmaceuticalbrand 新舒沐 (Xinshumu)NMPA Class 1 innovative drug, approved Feb 2025liver-targeted PMEA prodrug